Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL-001 Study)
暂无分享，去创建一个
E. Kimby | J. Gribben | F. Bosch | M. Gobbi | O. Frankfurt | A. Chanan-Khan | S. Stilgenbauer | D. Mahadevan | M. Sekeres | C. Wendtner | S. Coutre | R. Furman | D. Hurd | A. Ferrajoli | L. Dreisbach | P. Hillmen | L. Uharek | A. Bloor | Jennie Zhang | Sheetal H Shah | L. M. Parseval